MediService SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MediService SA - overview
Established
1996
Location
-, -, Switzerland
Primary Industry
Healthcare
About
MediService SA is a Swiss company specializing in mail-order pharmacy services, delivering prescription medications and healthcare support directly to patients' homes, promoting convenient access to necessary treatments. Founded in 1996, MediService AG operates as a mail-order pharmacy focused on the secure delivery of prescription medications across Switzerland. The company was acquired by Galenica in October 2007, although the financial details of the deal remain undisclosed. The current CEO is André Luescher, who leads the organization in enhancing patient care solutions.
MediService AG specializes in a comprehensive mail-order pharmacy service, focusing on the delivery of prescription medications and a range of ancillary healthcare services. Their core offerings include the secure and discreet dispatch of medications throughout Switzerland, including chilled medications for complex therapies. In addition to medication distribution, the company provides specialized services such as health-related information and support for medication management, catering to patients dealing with chronic illnesses. MediService AG also features a home care nursing team that assists patients with their treatments free of charge, contingent on a doctor’s prescription.
The customer base primarily consists of patients with chronic conditions seeking convenient, at-home healthcare solutions within the Swiss market. MediService AG generates revenue primarily through the sale of prescription medications delivered via mail-order, alongside additional services such as home care support and patient education. The company’s transactional structure includes direct-to-consumer sales, where patients order medications through their platform and receive them at home, often without additional shipping fees. Subscription models may also be utilized for ongoing health management services, though specific details on pricing plans are not disclosed.
Revenue is bolstered by the provision of specialized services that enhance patient care, strengthening the firm's position in the healthcare sector. The company’s focus on patient-centered services aligns with its mission to facilitate better management of chronic health conditions at home. MediService AG's future growth strategy includes the development and launch of new health management products, though specific release dates have not been disclosed. The company aims to expand its operations beyond Switzerland into neighboring European markets to reach more patients.
The funding from the 2007 acquisition by Galenica will support these initiatives, optimizing their service offerings and enhancing infrastructure to facilitate expansion.
Primary Industry
Healthcare
Sub Industries
Healthcare
Website
www.mediservice.ch
Company Stage
Acquired
Total Amount Raised
Subscriber access only
MediService SA - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | MediService SA | - | ||||||||
| Growth | Completed | MediService SA | - |
Displaying 1 - 2 of 2

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.